A383930 logo

DT&CRO KOSDAQ:A383930 Stock Report

Last Price

₩5.89k

Market Cap

₩75.0b

7D

5.4%

1Y

-68.0%

Updated

02 Jan, 2025

Data

Company Financials

A383930 Stock Overview

Operates as a full-service CRO provider in South Korea. More details

A383930 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

DT&CRO CO., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for DT&CRO
Historical stock prices
Current Share Price₩5,890.00
52 Week High₩24,400.00
52 Week Low₩5,260.00
Beta0
1 Month Change7.09%
3 Month Change-13.89%
1 Year Change-67.97%
3 Year Changen/a
5 Year Changen/a
Change since IPO-14.95%

Recent News & Updates

Recent updates

Shareholder Returns

A383930KR Life SciencesKR Market
7D5.4%1.5%-1.5%
1Y-68.0%22.9%-10.9%

Return vs Industry: A383930 underperformed the KR Life Sciences industry which returned 22.9% over the past year.

Return vs Market: A383930 underperformed the KR Market which returned -10.9% over the past year.

Price Volatility

Is A383930's price volatile compared to industry and market?
A383930 volatility
A383930 Average Weekly Movement15.7%
Life Sciences Industry Average Movement10.2%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.8%
10% least volatile stocks in KR Market3.4%

Stable Share Price: A383930's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A383930's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
2017n/an/awww.dtncro.com/ko

DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea. It conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting. DT&CRO CO., Ltd.

DT&CRO CO., Ltd. Fundamentals Summary

How do DT&CRO's earnings and revenue compare to its market cap?
A383930 fundamental statistics
Market cap₩74.98b
Earnings (TTM)₩0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A383930 income statement (TTM)
Revenue₩0
Cost of Revenue₩0
Gross Profit₩0
Other Expenses₩0
Earnings₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did A383930 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 23:36
End of Day Share Price 2025/01/02 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DT&CRO CO., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution